Oregon Health Sciences University Researcher Presents Results Of Clinical Trials Of Possible Stroke-Fighting Drug

February 07, 1998

Results of citicoline trial to be presented this week at annual American Heart Association Stroke Conference

A stroke-fighting drug up for possible approval by the U.S. Food and Drug Administration showed mixed results in a nationwide clinical trial, according to research being presented this Saturday, February 7, at the annual American Heart Association Stroke and Circulation Conference in Orlando, Florida. Wayne Clark, M.D., associate professor of neurology, and director of the Oregon Stroke Center at Oregon Health Sciences University, was lead researcher in a multicenter clinical trial of citicoline. Citicoline, manufactured under the brand name Ceraxon (TM) by Massachussetts-based Interneuron Pharmaceuticals Inc. has shown promise of reducing stroke-related injury by stablizing cell membranes long enough to prevent large-scale brain cell damage after stroke.

The clinical trial, involving nearly 400 patients in 33 centers nationwide, showed no statistically significant difference in five areas--including full recovery and mortality rates, neurological and cognitive function--between patients with stroke who were given citicoline, and those who were given a placebo. "However, the drug did appear to produce an improvement over placebo in a subset of patients with moderate to severe strokes," said Clark. Patients were first given the drug or a placebo within a few hours of their stroke, then for six weeks afterward, with a six-week, post-treatment follow-up period. Interneuron submitted a New Drug Application for citicoline to the FDA in December. The drug is already being marketed in approximately 30 countries.

Clark is scheduled to present the results of the clinical trial on Saturday, February 7, 1998 at the Omni Rosen Hotel in Orlando, Florida. Call Henry Sessions at (503) 494-8231 if you wish to speak with Clark before the presentation.
-end-


Oregon Health & Science University

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.